The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients
Journal article published in 2018 by
Francesca Battaglin,
Marta Schirripa,
Federica Buggin,
Filippo Pietrantonio,
Federica Morano,
Giorgia Boscolo,
Giuseppe Tonini,
Eufemia Stefania Lutrino,
Jessica Lucchetti,
Lisa Salvatore 
,
Alessandro Passardi,
Chiara Cremolini ,
Ermenegildo Arnoldi,
Mario Scartozzi,
Nicoletta Pella
and other authors.
,
Alessandro Passardi,
Chiara Cremolini ,
Ermenegildo Arnoldi,
Mario Scartozzi,
Nicoletta Pella
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 